Stocks
Alexion Pharmaceuticals, Inc.ALXN
NASDAQHealthcareBiotechnology$182.50+0.00%
A biotechnology company focused on developing therapies for rare and life‑threatening diseases, particularly those involving the complement system of the immune response. Its flagship drugs, including Soliris and Ultomiris, became major treatments for ultra‑rare blood and neurological disorders and ...
Market Cap: $052W Range: $99.91 – $187.45
Congressional Interest in Alexion Pharmaceuticals, Inc. (ALXN)
6 members of Congress have disclosed 50 trades in Alexion Pharmaceuticals, Inc. (ALXN), a Healthcare company. The buy/sell breakdown shows 21 purchases versus 27 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
6
Buys
21
Sells
27
Who in Congress Is Trading ALXN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-01-26 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2017-01-06 | JAMES R. LANGEVIN | sell | $15K – $50K |